Discover 1,707 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,707
Study of Olverembatinib (HQP1351) in Patients With CML-CP
for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Detroit MI, Toronto, Pittsburgh PA, Chicago IL,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06423911
Phase3, Recruiting
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Detroit MI, St Louis MO, Raleigh NC, Tampa FL,
Sponsor: MOMA Therapeutics
Sex: All
Age: 18+
Code: NCT06974110
Phase1, Recruiting
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Detroit MI, East Lansing MI, Greenfield WI,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07039916
Phase3, Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Detroit MI, Chicago IL, Milwaukee WI, Nicholasville KY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase2, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Ann Arbor MI, London, Columbus OH, Toronto,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: Detroit MI, Toronto, Pittsburgh PA, Chicago IL,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 16+
Code: NCT06617325
Phase3, Recruiting
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
for
Solid Tumor
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Fairfax VA,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06874335
Phase1, Recruiting
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumors
Location: Detroit MI, Toronto, Pittsburgh PA, Chicago IL,
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
for
Barretts Esophagus With Dysplasia, Barrett Esophagus,
Location: Ann Arbor MI, Cleveland OH, Pittsburgh PA, Chicago IL,
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT05753748
Recruiting
Opioid/Benzodiazepine Polydrug Abuse
for
Polysubstance Abuse
Location: Detroit MI
Sponsor: Wayne State University
Sex: All
Age: 18 - 70
Code: NCT03696017
Recruiting
Cannabidiol, Morphine, Pain
for
CBD, Chronic Pain
Location: Detroit MI
Sponsor: Wayne State University
Sex: All
Age: 18 - 55
Code: NCT04030442
Phase1, Recruiting
Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)
for
Hypertension, High Blood Pressure
Location: Detroit MI
Sponsor: Wayne State University
Sex: All
Age: 18+
Code: NCT06593496
Recruiting
Assessment of the Utility of the Pantheris Small Vessel (SV) System
for
Peripheral Arterial Disease
Location: Saint Clair Shores MI, Grand Rapids MI
Sponsor: Avinger, Inc.
Sex: All
Age: 18+
Code: NCT04793581
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Grand Rapids MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase3, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma